Xcell Therapeutics Inc. (KOSDAQ:373110)

Xcell Therapeutics Revenue

Xcell Therapeutics had revenue of 1.02B KRW in the quarter ending March 31, 2026, with 209.78% growth. This brings the company's revenue in the last twelve months to 2.64B, up 51.56% year-over-year. In the year 2025, Xcell Therapeutics had annual revenue of 1.95B with 0.76% growth.

• Revenue (ttm): 2.64B
• Revenue Growth: +51.56%
• P/S Ratio: 7.87
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 20.77B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.95B	14.65M	0.76%
Dec 31, 2024	1.93B	810.45M	72.11%
Dec 31, 2023	1.12B	103.86M	10.18%
Dec 31, 2022	1.02B	-946.25M	-48.12%
Dec 31, 2021	1.97B	1.43B	264.00%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 26, 2026

Data Sources Report a data error